M6-C Artificial Cervical Disc
-
Biologics
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient…
Read More » -
Spine
Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting
LEWISVILLE, Texas, June 1, 2023 /OrthoSpineNews/ – Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced…
Read More » -
Spine
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing…
Read More » -
Regulatory
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
August 2, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS
May 13, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Orthopaedic Surgeon, Dr. Jeffrey Carlson, first in Central and Eastern Virginia to implant the M6-C Artificial Cervical Disc
Dr. Jeffrey Carlson has been a part of Orthopaedic & Spine Center since 1999 and serves as the President and…
Read More » -
Spine
EmergeOrtho, P.A. Announces First Patient Implant in Durham, NC of the Next-Generation M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration
DURHAM, N.C., July 2, 2019 /PRNewswire/ — EmergeOrtho, P.A. today announced the first implant in Durham, NC of a patient with the M6-C™ artificial cervical…
Read More » -
Spine
Orthofix Announces First US Patient Implants Following FDA Approval of the M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration
April 23, 2019 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies,…
Read More » -
Spine
Full Two-Year Data from Orthofix M6-C Artificial Cervical Disc Study Shows Significant Improvement in Pain, Function and Quality of Life Scores
April 04, 2019 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies,…
Read More » -
Regulatory
MCRA Assists with Premarket Approval of the M6-C Artificial Cervical Disc
WASHINGTON, March 7, 2019 /PRNewswire/ — MCRA, LLC announced today its role in the successful Premarket Approval (PMA) application decision by the U.S.…
Read More » -
Spine
Orthofix Announces FDA Approval of the M6-C Artificial Cervical Disc to Treat Patients with Cervical Disc Degeneration
February 07, 2019 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies,…
Read More »